Sunitinib Scheduling in Metastatic Renal Cell Carcinoma (mRCC)

Clinical trial NCT02060370 · COMPLETED

Trial details

NCT number: NCT02060370
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Genitourinary Cancer Kidney Cancer

Start date: 2014-08-01
Primary completion: 2019-01-02
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.